Registry for Pancreatic Cancer

Registry to Evaluate Multi-modality Therapies for Pancreatic Cancer

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03001505

Enrollment

Registered

2016-12-23

Start date

2017-05-04

Completion date

2037-04-30

Last updated

2017-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Brief summary

This is an observational, prospective and retrospective registry of patients with pancreatic cancer treated in Duke University Health System, which will examine patient and treatment effects on cancer outcomes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Pancreatic cancer

Exclusion criteria

* Younger than 18 years of age

Design outcomes

Primary

Measure	Time frame	Description
Overall survival	10 years	Survival from Diagnosis to time of death

Secondary

Measure	Time frame	Description
Disease-free survival	10 years	length of time with no evidence of disease
Metastasis	10 years	Radiographic or surgical evidence of disease spread beyond the pancreas (or resection bed if post surgery).
Local recurrence	10 years	Radiographic evidence of disease recurrence in the resection bed, if post surgery.

Countries

United States

Outcome results